Leadership

Management Team

Michael S. Anderson
Chief Executive Officer
Michael S. Anderson was appointed Chief Executive Officer of Flamel Technologies in March 2012. Previously, Anderson was the President and Chief Executive Officer of Éclat Pharmaceuticals, a specialty pharma company located in St. Louis, Missouri. Éclat, which began operation in November 2010, was acquired by Flamel in March of this year. Prior to Eclat, Anderson was at KV Pharmaceutical Company, where he served as President and CEO of its generic business, ETHEX Corporation, and was also the President and CEO of Ther-Rx Corporation, a leader in women’s healthcare. He also was with Schein Pharmaceutical and started his career with A.H. Robins Company. He will be relocating to Lyon, France and Éclat will continue to be operated out of St. Louis.
Steven A. Lisi
Senior Vice President, Business and Corporate Development
Mr. Lisi was appointed Senior Vice President, Business and Corporate Development in June 2012. Previously, he served as partner at Deerfield Management, a leading global healthcare focused hedge fund, between 2007 and 2012. Prior to that, he was founder and managing member/portfolio manager at Panacea Asset Management LLC (New York) between 2005 and 2007, and healthcare portfolio manager at Millenium Partners (New York) between 2002 and 2005. Between 1994 and 2002, he served as analyst in several companies. Mr. Lisi is a graduate of Pepperdine University (Malibu, California).
Phillandas T. Thompson, J.D., M.B.A.
Senior Vice President, General Counsel
Mr. Thompson was appointed Senior Vice President, General Counsel in November 2013. Previously, he served as Vice President, Legal Affairs at West-Ward Pharmaceutical Corp. (2012-2013), Vice President, General Counsel at Paddock Laboratories, Inc. (2010-2012), Vice President, Strategic Business Transactions and Assistant General Counsel at KV Pharmaceutical (2006-2010), Associate General Counsel and Assistant Secretary at Barr Pharmaceutical (2002-2006), and Corporate Associate at White & Case LLP (1998-2002). Mr. Thompson is a member of the New York Bar, the Missouri Bar, and the Minnesota Bar and has several other professional affiliations. Mr. Thompson earned a B.A. from Washington University in St. Louis and  is also  a graduate of the University of Michigan Law School (Juris Doctor) and the University of Michigan Business School (Master of Business Administration).
Gregg Stetsko, Ph.D.
Vice President, Research and Development
Dr. Stetsko has over 30 years of experience in the pharmaceutical business, with roles of increasing responsibility at Sandoz, Sterling Winthrop, Ligand Pharmaceutical, and Amylin, where he was Vice President of Operations and Global Leader

for the Amylin-Lilly Exenatide Alliance.  More recently, he was Chief Scientific Officer for Eagle Pharmaceuticals and a Principal at Tahoe Consulting.  Dr. Stetsko earned a B.S. degree in Pharmacy from the University of Rhode Island and a Ph.D. in Industrial and Physical Pharmacy from Purdue University.

Siân Crouzet
Principal Financial Officer
Mrs. Sian Crouzet has been Principal Financial Officer of Flamel Technologies SA since March 2008. She previously worked as Financial Controller France for McCormick & Company Inc. Mrs. Crouzet also worked five years as an external auditor with Ernst and Young (France and UK). She is a UK Chartered Accountant and a graduate of Bradford University (UK).
Yves Bourboulou, Pharm.D.
Director, Manufacturing Facility
Mr. Yves Bourboulou is Director of Manufacturing Facility. He worked previously as Plant Manager at Pharmacia and Fresenius Kabi. Mr. Bourboulou previously held various senior positions including Quality Assurance Director and Chief Pharmacist Officer (CPO) in the Pharmaceutical Industry. He has more than 20 years experience in pharmaceutical production, quality and development.

Board of Directors

Stephen H. Willard
Chairman
former Chief Executive Officer, Chief Financial Officer and General Counsel of Flamel Technologies, Vice President of Biovail Corporation, Associate Director of Resolutions of the Federal Deposit Insurance Corporation (“FDIC”) of the USA, investment banker at Credit Suisse First Boston, and attorney with Gibson, Dunn Crutcher LLP and Shearman Sterling LLP; member of the Board of Directors of E-Trade Financial Corporation
Michael S. Anderson
Director
Chief Executive Officer of Flamel Technologies
Catherine Bréchignac, Ph.D.
Director
Permanent Secretary of the French Academy of Sciences and former Chairwoman of the French National Center for Scientific Research, CNRS
Guillaume Cerutti
Director
Chairman and CEO of Sotheby’s France
Francis J.T. Fildes, Ph.D.
Director
former Senior Vice President: Head of Global Development for AstraZeneca, PLC, Director of ProStrakan Group PLC and Fildes Partners Ltd, and a Fellow of the Royal Society of Medicine and the Royal Society of Chemistry
The Honorable Craig Stapleton
Director
former United States Ambassador to France
Elie Vannier
Director
former Group Managing Director of WALLY and former Chief Operating Officer of GrandVision SA, Director of Ingénico, Famar, Conbipel and Deputy Chairman of the Supervisory Board Groupe Loret

Scientific Advisory Board

Catherine Bréchignac, Ph.D.
Chairman
Permanent Secretary of the French Academy of Sciences and former Chairwoman of the French National Center for Scientific Research, CNRS
Professor Christian Trepo, MD, Ph.D. Emeritus professor at the Claude Bernard University (Lyon 1), Professor of hepato-gastroenterology at the A. Carrel Faculty of Medicine, former Head of the Internal Medicine Department and Head of the Hepato-Gastroenterology Department (Hôtel Dieu, Hospices Civils de Lyon).
Francis J.T. Fildes, Ph.D.
Former Senior Vice President: Head of Global Development for AstraZeneca, PLC, Director of ProStrakan Group PLC and Fildes Partners Ltd,
Fellow of the Royal Society of Medicine and the Royal Society of Chemistry
Patrick Couvreur, Ph.D. Professor at University Paris Sud, senior member of the Institut Universitaire de France, chairman teacher of technological innovation at Collège de France
Professor Jean-Christophe Leroux full Professor in Drug Formulation and Delivery at ETH Zurich, associate editor of the European Journal of Pharmaceutics and Biopharmaceutics, member of editorial boards of several journals including the Journal of Controlled Release and the Journal of Pharmaceutical Sciences.